Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,273,238
+$1,685,047 QoQ
Shares Held
116,598
+7.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#124
of 1,603 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds $3,542,546,853 across 13 Drug Manufacturers - General names. NVS ranks #12 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
5,307,020 | $1,006,317,132 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,966,523 | $509,698,205 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
8,585,846 | $494,716,446 | |
| 4 | NVO |
Novo Nordisk A S
|
8,270,785 | $396,501,432 | |
| 5 | LLY |
ELI LILLY & Co
|
249,935 | $299,779,562 | |
| 6 | JNJ |
Johnson & Johnson
|
1,127,893 | $286,450,985 | |
| 7 | ABBV |
AbbVie Inc.
|
856,797 | $215,604,397 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
959,904 | $121,274,271 |
All Filings in NVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,273,238 | 116,598 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $16,588,191 | 108,597 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $108,638,388 | 787,977 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $102,215,343 | 916,894 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,075,470 | 11,052 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $103,508,798 | 899,920 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $67,145,493 | 630,711 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $43,064,292 | 445,201 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,644,525 | 55,903 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,628,660 | 35,624 | Shares | Defined | 2023-11-14 | |
| 2023-03-31 | $16,251,984 | 176,652 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $374,408,879 | 4,127,082 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $123,799,539 | 1,628,727 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $132,643,884 | 1,569,193 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $174,846,964 | 1,992,558 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $85,873,847 | 981,752 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $55,395,236 | 677,369 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $30,720,508 | 336,700 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $17,237,383 | 201,654 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $454,680 | 4,815 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $148,216,189 | 1,704,418 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $267,986,195 | 3,068,310 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $403,512,691 | 4,894,029 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||